Prenosis Inc. Receives BARDA Contract to Study Utility of Its Sepsis Diagnostic Tool

The Sepsis ImmunoScore™ is a pathogen-agnostic, host-based digital diagnostic that uses Artificial Intelligence/Machine Learning (AI/ML) to predict sepsis based on a combination of clinical parameters and protein biomarkers CHICAGO, June 7, 2023 /PRNewswire/ — Prenosis Inc., an artificial intelligence company enabling precision medicine in acute care, announced today it has been awarded a contract from … Read more